Scott Steiger, MD
Professor
Medicine
School of Medicine

Since growing up in southeastern Kansas, Dr. Steiger has moved all over the country for school and jobs, landing on faculty at UCSF in 2012 at the Mt. Zion campus and transitioning to the San Francisco General campus in 2016.

Show full bio (60 words) Hide full bio

Board-certified in both internal medicine and addiction medicine, Dr. Steiger is the Deputy Medical Director of the Opiate Treatment Outpatient Program at SF General, where he also maintains a primary care practice and attends on the inpatient Addiction Care Team. His primary academic interest is in teaching about addiction and its treatments.

Awards

Show all (5) Hide

• Excellence in Interprofessional Teaching Award, UCSF Academy of Medical Educators, 2020
• Best Workshop, Association for Medical Education and Research on Substance Abuse, 2016
• Fellow, American College of Physicians, 2015
• Fellow, American Society of Addiction Medicine, 2015
• Excellence in Teaching Award, UCSF Academy of Medical Educators, 2015

Education & Training

Show all (3) Hide

• Residency Internal Medicine University of Washington 2008
• M.D. Washington University 2005
• B.S. Biology and History Duke University 1998

Publications (10)

Top publication keywords:
Practice Patterns, Physicians'Academic Medical CentersBuprenorphineAnalgesics, OpioidNarcotic AntagonistsPrimary Health CareTravelMethadoneCultural CompetencyOpioid-Related DisordersSubstance Abuse DetectionOpiate Substitution TreatmentNaloxoneChronic PainMotivational Interviewing

• "Get in and get out, get on with life": Patient and provider perspectives on methadone van implementation for opioid use disorder treatment.
  The International journal on drug policy 2023 Suen LW, Steiger S, Shapiro B, Castellanos S, Joshi N, Lambdin BH, Knight KR
• Predictors of Linkage to an Opioid Treatment Program and Methadone Treatment Retention following Hospital Discharge in a Safety-Net Setting.
  Substance use & misuse 2023 Tierney HR, Takimoto SW, Azari S, Steiger S, Martin M
• Adapting methadone inductions to the fentanyl era.
  Journal of substance abuse treatment 2022 Buresh M, Nahvi S, Steiger S, Weinstein ZM
• "I wanted something that was more flexible": A qualitative study of patient preferences on choosing buprenorphine over methadone in a large, safety-net hospital opioid treatment program.
  Substance abuse 2022 Checkley L, Steiger S, Knight KR
• Time to ACT: launching an Addiction Care Team (ACT) in an urban safety-net health system.
  BMJ open quality 2021 Martin M, Snyder HR, Coffa D, Steiger S, Clement JP, Ranji SR, Azari S, Nguyen OK, Lum PJ

Show all (5 more) Hide

• What Should I Know About Opioids?
  JAMA internal medicine 2019 Incze MA, Steiger S
• Increasing Naloxone Co-prescription for Patients on Chronic Opioids: a Student-Led Initiative.
  Journal of general internal medicine 2018 Freise JE, McCarthy EE, Guy M, Steiger S, Sheu L
• Predictors of higher-risk chronic opioid prescriptions in an academic primary care setting.
  Substance abuse 2016 Bauer SR, Hitchner L, Harrison H, Gerstenberger J, Steiger S
• Teaching residents screening, brief intervention, and referral to treatment (SBIRT) skills for alcohol use: Using chart-stimulated recall to assess curricular impact.
  Substance abuse 2015 Wamsley MA, Steiger S, Julian KA, Gleason N, O'Sullivan PS, Guy M, Satterfield JM
• Cultural Adaptation of Screening, Brief Intervention and Referral to Treatment Using Motivational Interviewing.
  Journal of addiction medicine 2015 Satre DD, Manuel JK, Larios S, Steiger S, Satterfield J